TEAMING UP FOR
Cyberonics, a medical device technology company,
began a research partnership with Purdue six years
ago to improve the effectiveness of its products.
Milton Morris, senior vice president of research and development for Cyberonics, holds an implantable neurostimulator
that delivers vagus nerve stimulation (VNS) therapy to control epilepsy and depression. Cyberonics is working with
Purdue’s Weldon School of Biomedical Engineering to increase these devices’ effectiveness and to discover alternative
means by which to power them.